Increasing Exposure to Drug-Drug Interactions Between 1992 and 2005 in People Aged ≥55 Years

Author： Becker Matthijs L.   Visser Loes E.   Teun van Gelder  

Publisher： Adis International

ISSN： 1170-229X

Source： Drugs & Aging, Vol.25, Iss.2, 2008-01, pp. : 145-152

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Clinically relevant drug–drug interactions between antiretrovirals and antifungals

By Vadlapatla Ramya Krishna   Patel Mitesh   Paturi Durga K   Pal Dhananjay   Mitra Ashim K  

Expert Opinion on Drug Metabolism and Toxicology, Vol. 10, Iss. 4, 2014-04 ,pp. : 561-580

Informa Healthcare

Access to resources Recommend Favorite

Maraviroc potential drug-drug interactions

By  

Reactions Weekly, Vol. 1, Iss. 1207, 2008-01 ,pp. : 5-5

Adis International

Access to resources Recommend Favorite

Transporter-mediated drug––drug interactions

By Müüller Fabian   Fromm Martin F  

Pharmacogenomics, Vol. 12, Iss. 7, 2011-07 ,pp. : 1017-1037

Future Medicine

Access to resources Recommend Favorite

Predicting inductive drug–drug interactions

By Liddle Christopher   Robertson Graham R  

Pharmacogenomics, Vol. 4, Iss. 2, 2003-03 ,pp. : 141-152

Future Medicine

Access to resources Recommend Favorite

Patient- and physician-related risk factors for hyperkalaemia in potassium-increasing drug–drug interactions

By Eschmann Emmanuel   Beeler Patrick   Kaplan Vladimir   Schneemann Markus   Zünd Gregor   Blaser Jürg  

European Journal of Clinical Pharmacology, Vol. 70, Iss. 2, 2014-02 ,pp. : 215-223

Springer Publishing Company

Access to resources Recommend Favorite